Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Quentin Saint-Genis und 7 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1070, PHAR2, Université de Poitiers, Poitiers, France. Hauptthemen laut MEDLINE: Gentamicins, Antibiotic Prophylaxis, Anti-Bacterial Agents, Surgical Wound Infection. Die Arbeit nennt 27 Literaturangaben. Gefördert von: University Hospital of Poitiers.
Abstract (Originalsprache)
Introduction
Surgical site infections (SSIs) are a leading cause of healthcare-associated infections, particularly in abdominal surgery. In patients allergic to beta-lactams, gentamicin is often used for surgical antibiotic prophylaxis (SAP), but its efficacy is questioned due to limited tissue-level pharmacokinetic/pharmacodynamic (PK/PD) data. Materials and Methods We conducted a monocentric prospective study involving eight adult patients undergoing major abdominal surgery who received gentamicin (5 mg/kg IV) for SAP. Subcutaneous unbound gentamicin concentrations were measured using microdialysis over 6 h. Plasma and tissue PKs were analysed using nonlinear mixed-effects modelling. Monte Carlo simulations assessed the probability of target attainment (PTA) for Cmax/MIC >8 at doses of 5 and 8 mg/kg, using EUCAST MIC distributions for Escherichia coli and Staphylococcus aureus.
Results
A total of 246 samples were collected (100 plasma and 146 microdialysate). Subcutaneous gentamicin concentrations were lower than plasma concentrations throughout the 0–6 h interval. Mean Cmax values were 43.7 ± 4.5 mg/L in plasma and 17.8 ± 11.5 mg/L in subcutaneous tissue. Given the lack of defined tissue PK/PD targets in surgical prophylaxis, a plasma-based Cmax/MIC > 8 target was used for PTA simulations. At 5 mg/kg, PTA was suboptimal for MIC ≥1 mg/L in subcutaneous tissue. Simulations showed that increasing the dose to 8 mg/kg improved the cumulative fraction of response against E. coli and S. aureus from 70% and 79% to 80% and 87%, respectively.
Discussion
This study highlights insufficient subcutaneous gentamicin exposure with standard SAP dosing. An 8 mg/kg dose improved tissue PK/PD target attainment, supporting updated dosing recommendations for beta-lactam-allergic patients. Further research is needed to validate safety and efficacy in broader populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- INSERM U1070, PHAR2, Université de Poitiers, Poitiers, France.
- Service d'anesthésie-Réanimation et Médecine Péri-Opératoire, CHU de Poitiers, Poitiers, France.
- Service de Toxicologie-Pharmacocinétique, CHU de Poitiers, Poitiers, France.
ORCID-Profile: Quentin Saint-Genis, Alexia Chauzy, Matthieu Boisson
Förderung
- University Hospital of Poitiers
Zitieren
APA
Saint-Genis, Q., Marchand, S., Chauzy, A., Mirfendereski, H., Kostencovska, A., Teixeira, N., Gregoire, N., & Boisson, M. (2026). Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag071
Vancouver
Saint-Genis Q, Marchand S, Chauzy A, Mirfendereski H, Kostencovska A, Teixeira N, et al. Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag071
BibTeX
@article{SaintGenis2026,
author = {Saint-Genis, Quentin and Marchand, Sandrine and Chauzy, Alexia and Mirfendereski, Helene and Kostencovska, Angela and Teixeira, Nadia and Gregoire, Nicolas and Boisson, Matthieu},
title = {Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag071}
}
EUVIMED